Appropriate Dosing & Administration of Intraoperative IV Opioids During General Anesthesia Webcast

Release date: April 8, 2013
Expiration date: April 8, 2014
Estimated time to complete activity: 1.5 hour

Faculty Presenters

Adam I. Levine, MD
Department of Anesthesiology
Mount Sinai School of Medicine
Program Director
Residency Training Program
Mount Sinai Hospital
New York, New York

Robert J. McCarthy, PharmD
Research Professor
Department of Anesthesiology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Video Case Study Presenter

Jeffrey G. Priest, MD
Medical Director
Central Utah Surgical Center
Provo, Utah

Program Overview

Healthcare providers who practice in hospitals and health-systems play a vital role in maintaining and promoting public health. Recent changes in surgical environments and goals of perioperative patient care have afforded anesthesiologists and pharmacists with an opportunity to play an important role in the selection of anesthetic agents at their institution. This Practitioner’s Edge program examines the role of anesthesiologists and health-system pharmacists, current issues in clinical practice where intravenous (IV) agents are part of anesthesia techniques, and opportunities for collaboration amongst the treatment team to improve patient care.

Recommendations for the use of IV hypnotics and short-acting IV opioids, as well as clinical issues such as medical history, surgical intervention, or when tight hemodynamic control is necessary, are all important to consider when choosing an anesthetic agent.

This activity will review several clinical situations in which anesthetic agents are selected based on specific patient needs.

Target Audience

This educational activity has been designed to meet the educational needs of anesthesiologists, health-system pharmacists, and other healthcare providers involved in the care of patients who receive general anesthesia.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Review the pharmacokinetic/pharmacodynamic properties that differentiate available fentanyl analogs used for general anesthesia
  • Ensure that correct doses of intravenously administered short-acting opioids are used intraoperatively
  • Describe patient responses that influence intraoperative decision making with fentanyl-based opioids

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty/planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Adam I. Levine, MD
Consultant: Mylan Specialty

Jeffrey G. Priest, MD
Consultant: Drug Enforcement Agency, Utah Department of Occupatioal and Professional Licensing

Sean M. Gregory, PhD, and Robert J. McCarthy, PharmD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Directions to the Learner

There are no fees for participating and receiving CME credit for this activity. During the period of April 8, 2013 through April 8, 2014, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)



Minimum System Requirements

Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10

Click here for more information on minimum system requirements.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Mylan Specialty, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Mylan Specialty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

continue to pretest


For questions about the accreditation of this program, please contact Integrity Continuing Education, Inc. at (888) 255-1009 or This email address is being protected from spambots. You need JavaScript enabled to view it. .

Sponsored by: integrity

Supported by an educational grant from:

mylan logo us 2 color